Sanofi: all 2,424 studies
Page 4 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) PatientsCompletedNCT03194867Phase 1/2Results posted
- Randomized Study of the Efficacy and Safety of a Single Dose of Synvisc-One® in Chinese Patients With Symptomatic Osteoarthritis of the KneeCompletedNCT03190369Phase 3Results posted
- Immunogenicity and Safety of a Purified Vero Rabies VaccineCompletedNCT03145766Phase 2Results posted
- A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)CompletedNCT03093480Phase 4Results posted
- Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 YearsCompletedNCT03077438Phase 3Results posted
- A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase AlfaActive, not recruitingNCT03019406Phase 2Results posted
- Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In ChinaCompletedNCT03001011Phase 3Results posted
- Safety and Efficacy of Isatuximab in Lymphoblastic LeukemiaTerminatedNCT02999633Phase 2Results posted
- Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®CompletedNCT02993757Phase 3Results posted
- Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy SubjectsTerminatedNCT02992418Phase 3Results posted
- Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma PatientsCompletedNCT02990338Phase 3Results posted
- Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With HypercholesterolemiaCompletedNCT02984982Phase 4Results posted
- Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast CancerTerminatedNCT02984683Phase 2Results posted
- Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®CompletedNCT02979535Phase 3Results posted
- Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract InfectionCompletedNCT02979431Phase 2Results posted
- A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes MellitusCompletedNCT02973321Phase 2Results posted
- Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in ToddlersCompletedNCT02955797Phase 3Results posted
- Evaluation of Dupilumab in Children With Uncontrolled AsthmaCompletedNCT02948959Phase 3Results posted
- Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic SclerosisCompletedNCT02921971Phase 2Results posted
- Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy ChildrenCompletedNCT02915302Phase 4Results posted
- A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal PolypsCompletedNCT02912468Phase 3Results posted
- Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 FormulationsCompletedNCT02908269Phase 4Results posted
- A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene MutationTerminatedNCT02906020Phase 2Results posted
- Controlled Clinical Study of Dupilumab in Patients With Nasal PolypsCompletedNCT02898454Phase 3Results posted
- An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedNCT02890992Phase 2Results posted
- Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)CompletedNCT02878603Phase 3Results posted
- Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on DialysisTerminatedNCT02859896Phase 3Results posted
- Study of Lademirsen (SAR339375) in Patients With Alport SyndromeTerminatedNCT02855268Phase 2Results posted
- A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque PsoriasisCompletedNCT02852967Phase 2Results posted
- Study of Tesevatinib Monotherapy in Patients With Recurrent GlioblastomaCompletedNCT02844439Phase 2Results posted
- Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and OlderCompletedNCT02842866Phase 3Results posted
- Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate VaccineCompletedNCT02842853Phase 3Results posted
- A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host DiseaseCompletedNCT02841995Phase 2Results posted
- Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose ScheduleCompletedNCT02824198Phase 2Results posted
- Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma PatientsCompletedNCT02812706Phase 1/2Results posted
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodCompletedNCT02787551Phase 3Results posted
- Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe DiseaseCompletedNCT02782741Phase 3Results posted
- An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)CompletedNCT02776735Phase 2Results posted
- Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate VaccineCompletedNCT02752906Phase 3Results posted
- Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive AdultsCompletedNCT02741128Phase 2Results posted
- Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor AgonistCompletedNCT02738151Phase 4Results posted
- Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT02735044Phase 3Results posted
- Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With HypercholesterolemiaCompletedNCT02715726Phase 3Results posted
- A Study of PRN1008 in Adult Patients With Pemphigus VulgarisCompletedNCT02704429Phase 2Results posted
- A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes MellitusCompletedNCT02688933Phase 4Results posted
- A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary FibrosisCompletedNCT02688647Phase 2Results posted
- Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)CompletedNCT02642159Phase 4Results posted
- Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in VietnamCompletedNCT02640404Phase 2Results posted
- Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years EarlierCompletedNCT02633787Phase 4Results posted
- Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of AgeCompletedNCT02628444Phase 2Results posted
- Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose ScheduleCompletedNCT02623725Phase 2Results posted
- Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal MetastasesCompletedNCT02616393Phase 2Results posted
- Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult SubjectsCompletedNCT02591290Phase 4Results posted
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy SubjectsCompletedNCT02587520Phase 1/2Results posted
- Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)CompletedNCT02585778Phase 3Results posted
- Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of StatinCompletedNCT02584504Phase 3Results posted
- Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With AsthmaCompletedNCT02573233Phase 2Results posted
- Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in AdultsCompletedNCT02563093Phase 4Results posted
- Bioavailability of Belumosudil (KD025) in Healthy Male SubjectsCompletedNCT02557139Phase 1Results posted
- An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or BCompletedNCT02554773Phase 1/2Results posted
- Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic PurpuraCompletedNCT02553317Phase 3Results posted
- Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 to 60 YearsCompletedNCT02550197Phase 3Results posted
- Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy ChildrenCompletedNCT02539108Phase 4Results posted
- Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Completed Phase 2 or Phase 3 StudiesCompletedNCT02536755Phase 3Results posted
- Evaluation of Dupilumab in Patients With Severe Steroid Dependent AsthmaCompletedNCT02528214Phase 3Results posted
- A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTerminatedNCT02521870Phase 1/2Results posted
- An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid ArthritisCompletedNCT02518620Phase 2Results posted
- (NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid TumorsCompletedNCT02508532Phase 1Results posted
- Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) ScaleCompletedNCT02502149Phase 3Results posted
- To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTerminatedNCT02497612Phase 2Results posted
- Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy SubjectsCompletedNCT02492165Phase 3Results posted
- Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry DiseaseCompletedNCT02489344Phase 2Results posted
- Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted AgentCompletedNCT02485691Phase 4Results posted
- Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)CompletedNCT02476006Phase 3Results posted
- Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in IndiaCompletedNCT02451358Phase 3Results posted
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)CompletedNCT02451137Phase 4Results posted
- A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus ErythematosusCompletedNCT02437890Phase 2Results posted
- Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)CompletedNCT02414854Phase 3Results posted
- Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat TreatmentCompletedNCT02389452Phase 4Results posted
- Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or EnzalutamideTerminatedNCT02379390Phase 2Results posted
- A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)CompletedNCT02373202Phase 3Results posted
- Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary FibrosisCompletedNCT02345070Phase 2Results posted
- Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)CompletedNCT02332590Phase 3Results posted
- Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic MedicationsCompletedNCT02320721Phase 3Results posted
- Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line TherapyCompletedNCT02317627Phase 2Results posted
- A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid ArthritisCompletedNCT02309359Phase 2Results posted
- Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin GlargineCompletedNCT02294474Phase 3Results posted
- A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)CompletedNCT02293902Phase 3Results posted
- Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase DeficiencyCompletedNCT02292654Phase 1/2Results posted
- Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and TaiwanCompletedNCT02289963Phase 3Results posted
- A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid ArthritisCompletedNCT02287922Phase 2Results posted
- Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineCompletedNCT02273180Phase 3Results posted
- Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell LymphomaTerminatedNCT02266147Phase 1/2Results posted
- Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in AdultsCompletedNCT02258334Phase 4Results posted
- Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409CompletedNCT02255656Phase 4Results posted
- An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia ACompletedNCT02234323Phase 3Results posted
- Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia BCompletedNCT02234310Phase 3Results posted
- Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, ChinaCompletedNCT02228980Phase 4Results posted
- Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry DiseaseCompletedNCT02228460Phase 2Results posted
- Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza VaccineCompletedNCT02222870Phase 4Results posted